Confluence Investment Management LLC Charles River Laboratories International, Inc. Transaction History

Confluence Investment Management LLC

$6.32 Billion
Q4 2025

A detailed history of Confluence Investment Management LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Confluence Investment Management LLC holds 105,626 shares of CRL stock, worth $17.7 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares

105,626

Previous 95,963 10.07%

Holding current value

$17.7 Million

Previous $15 Million 18.06%

% of portfolio

0.28%

Previous 0.22%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2025 Jan 05, 2026	BUY	$167.03 - $197.04 $1.61 Million - $1.9 Million	9,663 Added 10.07%	105,626 $17.7 Million
Q3 2025 Oct 14, 2025	SELL	$145.57 - $178.99 $183,854 - $226,064	-1,263 Reduced 1.3%	95,963 $15 Million
Q2 2025 Jul 01, 2025	BUY	$99.75 - $151.89 $69,825 - $106,322	700 Added 0.73%	97,226 $14.8 Million
Q1 2025 Apr 01, 2025	BUY	$150.52 - $190.14 $530,131 - $669,673	3,522 Added 3.79%	96,526 $14.5 Million
Q4 2024 Jan 02, 2025	SELL	$178.58 - $220.69 $349,123 - $431,448	-1,955 Reduced 2.06%	93,004 $17.2 Million

Q3 2024 Oct 31, 2024	SELL	$187.96 - $245.29 $58,831 - $76,775	-313 Reduced 0.33%	94,959 $18.7 Million
Q2 2024 Jul 01, 2024	SELL	$206.39 - $268.73 $347,767 - $452,810	-1,685 Reduced 1.74%	95,272 $19.7 Million
Q1 2024 Apr 01, 2024	SELL	$203.52 - $273.43 $700,515 - $941,146	-3,442 Reduced 3.43%	96,957 $26.3 Million
Q4 2023 Nov 05, 2024	BUY	$164.52 - $238.84 $370,992 - $538,584	2,255 Added 2.37%	97,214 $23 Million
Q3 2023 Oct 10, 2023	BUY	$194.44 - $217.61 $3.19 Million - $3.57 Million	16,398 Added 19.52%	100,399 $19.7 Million
Q2 2023 Jul 03, 2023	BUY	$183.71 - $210.25 $15.4 Million - $17.7 Million	84,001 New	84,001 $17.7 Million
Q4 2021 Jan 04, 2022	SELL	$351.38 - $448.68 $44.1 Million - $56.3 Million	-125,409 Closed	0 $0
Q3 2021 Oct 04, 2021	SELL	$372.64 - $458.3 $22.3 Million - $27.5 Million	-59,972 Reduced 32.35%	125,409 $51.8 Million
Q2 2021 Jul 01, 2021	SELL	$294.17 - $371.65 $3.09 Million - $3.9 Million	-10,503 Reduced 5.36%	185,381 $68.6 Million
Q1 2021 Apr 05, 2021	SELL	$249.67 - $299.48 $57,174 - $68,580	-229 Reduced 0.12%	195,884 $56.8 Million
Q4 2020 Jan 25, 2021	SELL	$222.0 - $252.62 $691,752 - $787,163	-3,116 Reduced 1.56%	196,113 $49 Million
Q3 2020 Oct 19, 2020	SELL	$175.56 - $226.45 $1.34 Million - $1.72 Million	-7,616 Reduced 3.68%	199,229 $45.1 Million
Q2 2020 Jul 01, 2020	BUY	$118.84 - $189.72 $4.81 Million - $7.68 Million	40,479 Added 24.33%	206,845 $36.1 Million
Q1 2020 Jun 03, 2020	BUY	$98.9 - $178.34 $82,680 - $149,092	836 Added 0.51%	166,366 $21 Million
Q1 2020 Apr 08, 2020	BUY	$98.9 - $178.34 $16.4 Million - $29.5 Million	165,530 New	165,530 $20.9 Million

Others Institutions Holding CRL

# of Institutions

645

Shares Held

51.6M

Call Options Held

194K

Put Options Held

174K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $8.54B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Confluence Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Confluence Investment Management LLC with notifications on news.

Account

Confluence Investment Management LLC Charles River Laboratories International, Inc. Transaction History